Skip to main content
Neil Shah, MD, Oncology, New York, NY

Neil J Shah MD

Hematologic Oncology


Physician

Request Appointment
  • 353 East 68th StreetNew York, NY 10065

  • Book by Phone+1(231) 508-9819

Overview of  Dr. Shah

Dr. Neil Shah is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Pramukhswami Medical College and has been in practice 7 years. He is one of 506 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 30 publications and over 500 citings.

Education & Training

  • MedStar Health Georgetown University
    MedStar Health Georgetown UniversityFellowship, Hematology and Medical Oncology, 2016 - 2019
  • Hackensack University Medical Center (Mountainside)
    Hackensack University Medical Center (Mountainside)Residency, Internal Medicine, 2012 - 2016
  • Pramukhswami Medical College
    Pramukhswami Medical CollegeClass of 2010

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2019 - 2026
  • NJ State Medical License
    NJ State Medical License 2014 - 2025
  • DC State Medical License
    DC State Medical License 2016 - 2020
  • VA State Medical License
    VA State Medical License 2017 - 2020
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Real-world outcomes of underrepresented patient populations treated with immune checkpoint inhibitors (ICIs): African American descent, poor ECOG performance status, a... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • New Combo Immunotherapy Prolongs Survival in Patients with Advanced Kidney Cancer
    New Combo Immunotherapy Prolongs Survival in Patients with Advanced Kidney CancerApril 22nd, 2022
  • Patient Groups Untested in Cancer Immunotherapy Trials Found to Also Benefit
    Patient Groups Untested in Cancer Immunotherapy Trials Found to Also BenefitMay 30th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: